OSCI

OSCI: Receives Paragraph IV Certification Notice for ANTARA(R) - 12/03 - 08:22 AM ET

Oscient Pharmaceuticals Receives Paragraph IV Certification Notice for ANTARA - 12/03 - 08:00 AM ET

Oscient Pharmaceuticals Finishes At New Low - 11/26 - 04:21 PM ET

Oscient Pharmaceuticals Corporation reports completion of convertible debt exchange offer - 11/25 - 08:00 AM ET

Oscient Pharmaceuticals Announces Determination of the Consideration Issuable in its Exchange Offer - 11/20 - 08:33 AM ET

OSCI: To Present At Lazard Capital Healthcare Conference @ 15:40 ET [delayed] - 11/18 - 02:24 PM ET

Oscient Pharmaceuticals to Participate in the Lazard Capital Markets 5th Annual Healthcare Conference - 11/13 - 04:00 PM ET

OSCI: To Present At Rodman & Renshaw Investment Conference @ 09:55 ET [delayed] - 11/11 - 08:23 AM ET

Oscient Pharmaceuticals Amends Exchange Offer - 11/07 - 08:10 AM ET

Oscient Pharmaceuticals to Participate in the Rodman & Renshaw 10th Annual Healthcare Conference - 11/05 - 04:30 PM ET

BRIEF-Oscient Pharmaceuticals reports Q3 results - 11/04 - 07:37 AM ET

Oscient Pharmaceuticals Reports Third Quarter 2008 Financial Results - 11/04 - 07:30 AM ET

OSCI: Q3 Earnings Call @ 08:30 ET Today [delayed] - 11/04 - 07:30 AM ET

Webcast Alert: Oscient Pharmaceuticals Announces Date for Release of Third Quarter Financial Results - 10/28 - 04:00 PM ET

NASDAQ Implements Temporary Suspension of Bid Price and Market Value of Publicly Held Shares Requirements; Oscient Compliance Period Extended to April 7, 2009 - 10/23 - 08:30 AM ET

OSCIENT PHARMACEUTICALS CORP SAYS COMMENCES EXCHANGE OFFER - 10/21 - 03:22 PM ET

Oscient Pharmaceuticals Commences Exchange Offer - 10/21 - 03:20 PM ET

Oscient Pharmaceuticals Receives NASDAQ Notice - 10/03 - 04:30 PM ET

Oscient Pharma Outlook Lowers - 10/02 - 07:10 AM ET

Oscient Pharmaceuticals Seeks to Improve Capital Structure through Proposed Exchange Offer with Holders of its 3.50% Convertible Senior Notes due 2011 - 09/10 - 08:24 AM ET

Page 1 of 4 1 2 3 4 Previous | Next

<< Back to Stock Index

RELATED SITES

Please call 1-213-955-5858 ext. 1

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.